TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Urine aMT6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious injuries limiting daily activities
Endpoint domain: Adverse events/effects
Primary endpoint: Estimated total direct cost of treatment per injury
Endpoint domain: Resource use
Primary endpoint: Incidence rate of keratinocyte carcinoma (KA)
Endpoint domain: Mortality/survival
Primary endpoint: Platelet aggregability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of wound assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about the food system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes towards food purchasing behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SNQ values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of self-medication during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of non-hormonal cancers
Endpoint domain: Mortality/survival
Primary endpoint: Risk of hormonal cancers
Endpoint domain: Mortality/survival
Primary endpoint: V̇O2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratings of pleasure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vaginal pain levels during retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal pain levels during retrieval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability and usability of myAID
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: continued breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean scores from the Brief Symptom Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean values of pre‐test and post‐test salivary cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of metoclopramide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-∞ of metoclopramide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T1/2 of metoclopramide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident severe infections requiring hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Total intraoperative fentanyl requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of infection after challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduced illness after challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total analgesic consumption of IV nalbuphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to void
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum PICP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic dysfunction as assessed by E/e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Facial skin quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: intended adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: trust
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anticipated satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of hepatic hydrothorax
Endpoint domain: Mortality/survival
Primary endpoint: first rescue analgesia time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total dose of IV paracetamol in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total oral intake on the first day postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of predictive biomarker in classifying treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: increased step velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced swing time variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Practice familiarity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived benefit of practices
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Headache intensity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIT-6 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable nociception response during general anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MVIC recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to dietary recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tobacco cessation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Multi-organ bodily distress syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom profile characterized by all symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritable bowel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: hemodynamic reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS pain scores at 6, 12, and 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of bleeding after 1 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total consumption of sufentanil within 36 h
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: depth accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb motor function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barthel index score
Endpoint domain: Life impact
Endpoint subdomain: Activity of daily living
Primary endpoint: Time to emergency department departure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Birth weight of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fascia length increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LSM values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FACIT-F score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in CRF
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in ESAS fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean islatravir triphosphate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in estimated salt intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of hyperglycemia with ketosis
Endpoint domain: Adverse events/effects
Primary endpoint: Acute episodes of atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HPV vaccination initiation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent with severe toxicities (grade ≥3)
Endpoint domain: Adverse events/effects
Primary endpoint: Time spent without AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Time with mild/moderate diarrhea, mucositis, fatigue and pain
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of ≥ 2 points on the mRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement on the BI of ≥ 40 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improved quality of life as measured by EQ-5D and SSQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ED50 of propofol combined with lidocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriateness of news delivery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: pain during catheter insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean anaerobic power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue index
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Participant satisfaction with treatment outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression to large drusen
Endpoint domain: Mortality/survival
Primary endpoint: Exercise behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Office SBP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Home SBP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in office SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clearance of SKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: recurrence of SKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Caregiver attendance rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: increased enjoyment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduced boredom
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Body iron stores (BIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to stable pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need to change to a strong opioid
Endpoint domain: Adverse events/effects
Primary endpoint: Genetic test uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients with abnormal metabolic indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Waist circumference ≥80 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TGs in the comprehensive group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Auditory learning enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive performance correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in QGSGS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement on GAIS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pulpal anesthetic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average chest compression depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interest in using LARCs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Initiation of LARC method
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neutralization titer (NT50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: proportion of FEV1 responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: reduction in rescue medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sensor‐based scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of programming steps
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: More severe dyspnea (MRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinically improved QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of detecting yeast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Volume and thickness reduction of coronal dentin and PCD above the alveolar crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum von Mises stress on the occlusal surface and cervical region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year probability of remaining stent-free
Endpoint domain: Mortality/survival
Primary endpoint: 5-year probability of no stricture recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Stent-related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability score of the decision aid
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of the decision aid for goals-of-care decision-making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neovascularization regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plus disease regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean insulin requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Obstructive apnoea–hypopnoea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: OSA‐18 total symptom score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot skin blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Range of motion (ROM) of the foot and ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power spectral density of heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acceptance of placebo treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Outcome expectations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUC insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AUC hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthy Eating Index 2015 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leisure walking at moderate-to-vigorous intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plaque biofilm accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean µTBS values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary fluoride ion concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary calcium ion concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of postoperative analgesic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIPN intensities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in intracranial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of subjects with < 10% bleeding sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in parent self-reported alcohol and opiate use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in child-reported neglectful parenting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Metacognitive ratings relative to same age peers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: psychological well-being score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volume-to-fullness benefits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Aggregate symptom score improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of HbA1c by more than 0.4%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of time spent in hypoglycaemia by more than 20 minutes over 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reductions in depression, anxiety, and stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived quality of parental couple relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean ease score of the cannulation procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean internal carotid artery stenosis diameter reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day rate of major adverse events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: CGuard patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-body energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-body carbohydrate oxidation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: counts of subgingival bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CST (Central Subfield Thickness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal adverse cardiac events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: complete eradication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: UPDRS-Ⅲ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUGT time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6MHW distance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: contact lens deposits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bulbar hyperaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood viral load (VL) ≥400 copies/mL at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Genital viral load (VL) ≥400 copies/mL at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Microhardness of dentine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calcium weight percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PS level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PF level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Global %VV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole lung index of ventilation volume to perfusion volume (V/Q) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days without pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean central foveal thickness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of caudal block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: balance domain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: goal achievement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Antibiotic days of therapy (DOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive margin status rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: gluteus medius activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of perceived lifetime risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gross Motor Function Measure-66 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall median score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes